She, J., Chen, X., Iyengar, M., & Li, J. (2026). Evaluation of Minimal Residual Disease as a Surrogate for Progression-Free Survival in Hematology Oncology Trials: A Meta-Analytic Review.
Chicago-Zitierstil (17. Ausg.)She, Jane, Xiaofei Chen, Malini Iyengar, und Judy Li. Evaluation of Minimal Residual Disease as a Surrogate for Progression-Free Survival in Hematology Oncology Trials: A Meta-Analytic Review. 2026.
MLA-Zitierstil (9. Ausg.)She, Jane, et al. Evaluation of Minimal Residual Disease as a Surrogate for Progression-Free Survival in Hematology Oncology Trials: A Meta-Analytic Review. 2026.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.